RETEVMO 80 mg/1

RETEVMO 80 mg capsules contain selpercatinib, a medication used for targeted therapy. This oral treatment is designed to address specific conditions related to genetic mutations.

RETEVMO 80 mg capsules are primarily used in the management of certain cancers associated with RET gene alterations. Selpercatinib is often prescribed for conditions where these genetic changes play a role. Patients and healthcare providers may explore 'what is RETevmo used for' to understand its applications in targeted therapy.

Common effects of RETevmo 80 mg capsules may include gastrointestinal issues, fatigue, and changes in taste. Some users might experience skin reactions or changes in blood pressure. Individual responses can vary, and it's important to discuss any concerns with a healthcare professional.

RETEVMO 80 mg capsules should be handled with care, following the guidance of a healthcare provider. It's essential to store the medication properly and adhere to prescribed usage. Patients should inform their healthcare provider about any existing medical conditions or other medications they are taking.

RETEVMO 80 mg capsules may interact with certain medications, including those metabolized by the liver's CYP enzymes. Alcohol and other substances that affect liver function could potentially influence the effectiveness or safety of selpercatinib. Always consult a healthcare provider before combining RETevmo with other treatments.